PTC Therapeutics reported $-0.83 in EPS Earnings Per Share for its fiscal quarter ending in June of 2025.


Fiscal Calendar Actual Consensus Previous Date
FY2025Q3 Sep/2025 -1.02 -1.39 Oct/23 2025
FY2025Q2 Jun/2025 -0.83 -1.07 -1.29 Aug/07 2025
FY2025Q1 Mar/2025 10.04 -1.35 -1.20 May/06 2025
FY2024Q4 Dec/2024 -0.85 -0.79 -2.06 Feb/27 2025
FY2024Q3 Sep/2024 -1.39 -1.51 -1.76 Nov/07 2024
FY2024Q2 Jun/2024 -1.29 -1.12 -2.66 Aug/08 2024
FY2024Q1 Mar/2024 -1.20 -1.29 -1.88 Apr/25 2024
FY2023Q4 Dec/2023 -2.06 -0.14 -1.89 Feb/29 2024
FY2023Q3 Sep/2023 -1.76 -1.07 -1.53 Oct/26 2023
FY2023Q2 Jun/2023 -2.66 -1.42 -2.13 Aug/03 2023
FY2023Q1 Mar/2023 -1.88 -1.73 -1.78 Apr/27 2023
FY2022Q4 Dec/2022 -1.89 -1.67 -2.03 Feb/21 2023


Eps Change Date
Acadia Pharmaceuticals USD 0.16 0.05 Jun/2025
Alnylam Pharmaceuticals USD 0.32 0.33 Jun/2025
Amgen USD 6.02 1.12 Jun/2025
Biogen USD 5.47 2.45 Jun/2025
BioMarin Pharmaceutical USD 1.44 0.31 Jun/2025
Cytokinetics USD -1.12 0.24 Jun/2025
Daiichi Sankyo JPY 46.03 0.28 Jun/2025
Gilead Sciences USD 2.01 0.2 Jun/2025
Incyte USD 1.57 0.41 Jun/2025
Ionis Pharmaceuticals USD 0.7 1.63 Jun/2025
Ironwood Pharmaceuticals USD 0.14 0.12 Jun/2025
Novartis USD 2.42 0.14 Jun/2025
Pfizer USD 0.78 0.14 Jun/2025
PTC Therapeutics USD -0.83 10.87 Jun/2025
Roche Holding CHF 8.57 1.66 Dec/2024
Sarepta Therapeutics USD 2.02 5.44 Jun/2025
TG Therapeutics USD 0.17 0.14 Jun/2025
Ultragenyx Pharmaceutical USD -1.17 0.4 Jun/2025
Vertex Pharmaceuticals USD 4.52 0.46 Jun/2025
Xencor USD -0.41 0.25 Jun/2025